AGIO
Agios Pharmaceuticals Inc
$37.93
0.82 (2.21%) Today
— up— down
Market Cap
$2.21B+10.4%
Revenue (TTM)
$66.82M+78.3%
Net Income (TTM)
$-431,181,288
$-431,181,288EPS (TTM)
-7.25
-7.25Shares Out
59.47M
59.47MOpen
$37.30
$37.30Previous Close
$37.11
$37.11Day Range
$36.35 – $38.38
$36.35 – $38.3852-Week Range
$22.24 – $46.00
$22.24 – $46.00Beta
0.56
0.56Volume
297.05K
297.05KAvg Volume
1.08M
1.08MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout AGIO
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.